FDA approves Lannett's cocaine-based nasal spray

07:05 EST 15 Jan 2020 | Pharmafile

It has been announced that the FDA has moved to approve Lannett Company’s Numbrino (cocaine hydrochloride) nasal solution for “the introduction of local anaesthesia of the mucous membranes for diagnostic procedures and surgeries”.

The therapy is notable for the presence of cocaine, an illegal, controlled substance which is infamously used recreationally, in its ingredients.  Its numbing properties and ability to prevent bleeding through the constriction of blood vessels can be highly beneficial in delicate operations.

read more

Original Article: FDA approves Lannett's cocaine-based nasal spray


More From BioPortfolio on "FDA approves Lannett's cocaine-based nasal spray"

Quick Search